The Morning After: The new iPad Air M4 is Apple's best overall tablet

Now that Apple is designing and engineering its own silicon, the updates come fast. It’s been less than two years since the ...
Hackaday

Acoustic Drone Detection On The Cheap With ESP32

We don’t usually speculate on the true identity of the hackers behind these projects, but when [TN666]’s accoustic ...
Hackaday

Arduino’s New AI-Centric Board Is The VENTUNO Q

There have been many questions about what direction Arduino would take after being bought by Qualcomm. Now it would seem that ...
Morningstar

Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early ...

"This new treatment option can redefine how we approach RRMM treatment by giving healthcare providers a regimen with improvement in PFS and OS and a well-characterized safety profile," said Dr.
Finanznachrichten

Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI plus DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as ...

Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens 83.3% of patients ...